Skip to main content
Voyageur Pharmaceuticals Ltd. logo

Voyageur Pharmaceuticals Ltd. — Investor Relations & Filings

Ticker · VM ISIN · CA92918C1014 TSXV Manufacturing
Open in API
Filings indexed 501 across all filing types
Latest filing 2025-03-31 Management Reports
Country CA Canada
Listing TSXV VM

About Voyageur Pharmaceuticals Ltd.

https://voyageurpharmaceuticals.ca/

Voyageur Pharmaceuticals Ltd. develops and supplies contrast media products for medical imaging, including CT scans and fluoroscopy. The company operates using a vertically integrated "Earth to Bottle" strategy, controlling the entire supply chain from raw mineral acquisition to finished pharmaceutical product. Voyageur owns a significant, high-purity barium sulfate resource, positioning it as a secure and sustainable supplier of pharmaceutical-grade barium sulfate, the active ingredient in its commercialized contrast agents (e.g., SmoothX® and SmoothHD® series). This vertical control aims to ensure supply security and cost competitiveness, primarily targeting the North American market. The company is also actively developing iodine-based contrast media and V-Gas® Effervescent Granules to expand its portfolio of diagnostic imaging solutions.

Recent filings

Filing Released Lang Actions
Annual MD&A - English.pdf
Management Reports Classification · 100% confidence The document is titled 'Management's Discussion & Analysis for the Year Ended November 30, 2024' and contains detailed analysis of the company's financial position, operational results, and forward-looking statements for the fiscal year ended November 30, 2024. It references audited annual consolidated financial statements prepared under IFRS and discusses financial performance, capital raising activities, and business strategy. The length of the document (15,000 characters) and the presence of substantive financial data and management commentary confirm it is a full MD&A report rather than a brief announcement or certification. Therefore, this document fits the category of Management Reports (MDA).
2025-03-31 English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).PDF
Regulatory Filings Classification · 85% confidence The document is a completed securities regulatory form (Form 13-501F1) submitted to the Alberta Securities Commission, detailing participation fees based on market values and including a management certification. It is not an annual or quarterly report, not an earnings release, not a management discussion, and not an investor presentation. It is a specific regulatory filing that does not fit other categories, so it falls under the general Regulatory Filings category.
2025-03-31 English
Audited annual financial statements – English.pdf
Audit Report / Information Classification · 91% confidence The document is titled “Consolidated Financial Statements for the years ended November 30, 2024 and 2023” and opens with an Independent Auditor’s Report. It includes the full set of audited IFRS financial statements (statements of financial position, comprehensive loss, cash flows, changes in equity) and detailed notes. This matches the definition of a standalone audit report and financial statements (Audit Report / Information), not a full narrative annual report, nor a brief announcement. Therefore, it should be classified under Audit Report / Information (AR). FY 2024
2025-03-31 English
Material change report - English.pdf
Regulatory Filings
2025-03-05 English
News release - English.pdf
Regulatory Filings Classification · 90% confidence The document is a corporate news release announcing the commencement of a new project (Frances Creek barium contrast media), grant funding, and clinical evaluation updates. It does not present financial results (so it is not an Earnings Release or Interim/Annual Report), nor does it announce management changes, dividends, share transactions, or M&A activity. It is not providing a report or filing but rather a general company announcement. Therefore, it falls into the fallback category of general regulatory announcements (RNS).
2025-03-04 English
News release - English.pdf
Regulatory Filings Classification · 70% confidence The document is a standard news release clarifying terms of a previously announced distribution and wholesaling agreement. It is not a financial report (annual, interim, audit, earnings), nor an AGM presentation, investor presentation, or M&A announcement. It does not announce share issues, dividends, management changes, or call transcripts. It simply provides a regulatory update via a press release format, placing it in the general “Regulatory Filings” category (RNS).
2025-03-03 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.